1. Home
  2. Detail

@hassanadoum128:

hassan
hassan
Open In TikTok:
Region: TD
Thursday 22 October 2026 18:34:19 GMT
235
41
9
1

Music

Download

No Watermark .mp4 (9.27MB) No Watermark(HD) .mp4 (9.27MB) Watermark .mp4 (9.27MB) Music .mp3

Comments

dajamal.djibirin
Dajamal Djibirin :
🥰🥰🥰
2026-10-23 19:48:29
0
haroun..01
haroun..01 :
💔💔💔
2026-10-23 19:02:33
0
user4377690068441
رمدن ادرحمن :
🥰🥰🥰
2026-10-23 14:03:25
0
mht12345249
MHT12345 :
✌️✌️✌️
2026-10-22 19:25:49
0
yamal.lamin34ahyamhtali6
AHYAMHTALI8766794763522500AHYA :
🥰🥰🥰
2026-10-22 19:12:02
0
user5486329901181
user5486329901181 :
✌️✌️✌️
2026-10-22 18:43:38
0
user18004628351926
بلا ل مو س :
✌️✌️✌️
2026-10-22 18:38:55
0
.90904318
عوض ءادم، 9090 :
[ضحكة مكتومة][ضحكة مكتومة][ضحكة مكتومة]
2026-10-22 18:38:28
0
user1078685818874
عبدو مطر :
🥰🥰🥰
2026-10-23 21:10:10
0
To see more videos from user @hassanadoum128, please go to the Tikwm homepage.

Other Videos

#
#
El Classico day 🔥 || Barcelona vs Real Madrid today #barcelona #realmadrid #elclassico #today #viral
El Classico day 🔥 || Barcelona vs Real Madrid today #barcelona #realmadrid #elclassico #today #viral
2025 Parada hazırlıq #parad #zəfərgünü
2025 Parada hazırlıq #parad #zəfərgünü
Standard CBC and CMP panels measure about 20 things and were designed in the mid 20th century to catch acute pathology. They don’t measure complement activation, cytokine networks, or the proteomic signatures of chronic immune dysregulation. The technology to measure thousands of proteins at once only became commercially viable around 2019, which is why paradigm-shifting research like this is happening now and not decades ago. A 2024 study by Cervia-Hasler et al. in Science used SomaScan proteomics on 113 long COVID patients and 39 controls. They identified persistent complement dysregulation including C7 complexes and terminal complement, plus markers of red blood cell injury and platelet activation. Almost none of these show up on routine bloodwork. A 2025 Nature Immunology study by Gao et al. replicated this in independent Swedish and UK cohorts and found multiple distinct biomarker signatures mapping to different long COVID symptom clusters. This kind of unbiased proteomic testing is not yet standard clinical care, and the assays used are not commercially available to the average patient. The findings need further replication and standardization before changing how chronic illness is diagnosed. The research does not say standard labs are useless. They are still essential for catching acute pathology. The point is they were never designed to catch chronic immune dysregulation. I’m not a doctor, just sharing research I find interesting. Sources: Cervia-Hasler et al. (2024). Persistent complement dysregulation with signs of thromboinflammation in active long COVID. Science. DOI: 10.1126/science.adg7942 Gao et al. (2025). Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology. DOI: 10.1038/s41590-025-02135-5 #chronicillness #immunesystem #inflammation #medicalgaslighting
Standard CBC and CMP panels measure about 20 things and were designed in the mid 20th century to catch acute pathology. They don’t measure complement activation, cytokine networks, or the proteomic signatures of chronic immune dysregulation. The technology to measure thousands of proteins at once only became commercially viable around 2019, which is why paradigm-shifting research like this is happening now and not decades ago. A 2024 study by Cervia-Hasler et al. in Science used SomaScan proteomics on 113 long COVID patients and 39 controls. They identified persistent complement dysregulation including C7 complexes and terminal complement, plus markers of red blood cell injury and platelet activation. Almost none of these show up on routine bloodwork. A 2025 Nature Immunology study by Gao et al. replicated this in independent Swedish and UK cohorts and found multiple distinct biomarker signatures mapping to different long COVID symptom clusters. This kind of unbiased proteomic testing is not yet standard clinical care, and the assays used are not commercially available to the average patient. The findings need further replication and standardization before changing how chronic illness is diagnosed. The research does not say standard labs are useless. They are still essential for catching acute pathology. The point is they were never designed to catch chronic immune dysregulation. I’m not a doctor, just sharing research I find interesting. Sources: Cervia-Hasler et al. (2024). Persistent complement dysregulation with signs of thromboinflammation in active long COVID. Science. DOI: 10.1126/science.adg7942 Gao et al. (2025). Identification of soluble biomarkers that associate with distinct manifestations of long COVID. Nature Immunology. DOI: 10.1038/s41590-025-02135-5 #chronicillness #immunesystem #inflammation #medicalgaslighting
#اليمن🇾🇪المملكة🇸🇦_عمان🇴🇲_الاردن🇯🇴ليبيا #creatorsearchinsights2026
#اليمن🇾🇪المملكة🇸🇦_عمان🇴🇲_الاردن🇯🇴ليبيا #creatorsearchinsights2026
#fyp #viral
#fyp #viral

About

Legal